These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32596800)

  • 21. Progressive osseous heteroplasia is not a Mendelian trait but a type 2 segmental manifestation of GNAS inactivation disorders: A hypothesis.
    Happle R
    Eur J Med Genet; 2016 May; 59(5):290-4. PubMed ID: 27058263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alternative Gnas gene products have opposite effects on glucose and lipid metabolism.
    Chen M; Gavrilova O; Liu J; Xie T; Deng C; Nguyen AT; Nackers LM; Lorenzo J; Shen L; Weinstein LS
    Proc Natl Acad Sci U S A; 2005 May; 102(20):7386-91. PubMed ID: 15883378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gs(alpha) mutations and imprinting defects in human disease.
    Weinstein LS; Chen M; Liu J
    Ann N Y Acad Sci; 2002 Jun; 968():173-97. PubMed ID: 12119276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pseudopseudohypoparathyroidism vs progressive osseous heteroplasia in absence of family history].
    Pereda A; González Oliva E; Riaño-Galán I; Pérez de Nanclares G
    Med Clin (Barc); 2015 Nov; 145(10):e25-7. PubMed ID: 25865609
    [No Abstract]   [Full Text] [Related]  

  • 25. Paternally inherited inactivating mutations of the GNAS1 gene in progressive osseous heteroplasia.
    Shore EM; Ahn J; Jan de Beur S; Li M; Xu M; Gardner RJ; Zasloff MA; Whyte MP; Levine MA; Kaplan FS
    N Engl J Med; 2002 Jan; 346(2):99-106. PubMed ID: 11784876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence of hormone resistance in a pseudo-pseudohypoparathyroidism patient with a novel paternal mutation in GNAS.
    Turan S; Thiele S; Tafaj O; Brix B; Atay Z; Abali S; Haliloglu B; Bereket A; Bastepe M
    Bone; 2015 Feb; 71():53-7. PubMed ID: 25464124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pseudohypoparathyroidism type Ia and pseudo-pseudohypoparathyroidism: the growing spectrum of GNAS inactivating mutations.
    Elli FM; deSanctis L; Ceoloni B; Barbieri AM; Bordogna P; Beck-Peccoz P; Spada A; Mantovani G
    Hum Mutat; 2013 Mar; 34(3):411-6. PubMed ID: 23281139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different mutations within or upstream of the GNAS locus cause distinct forms of pseudohypoparathyroidism.
    Jüppner H; Bastepe M
    J Pediatr Endocrinol Metab; 2006 May; 19 Suppl 2():641-6. PubMed ID: 16789629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pseudohypoparathyroidism: one gene, several syndromes.
    Tafaj O; Jüppner H
    J Endocrinol Invest; 2017 Apr; 40(4):347-356. PubMed ID: 27995443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autosomal-dominant pseudohypoparathyroidism type Ib is caused by different microdeletions within or upstream of the GNAS locus.
    Jüppner H; Linglart A; Fröhlich LF; Bastepe M
    Ann N Y Acad Sci; 2006 Apr; 1068():250-5. PubMed ID: 16831926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maternal
    Cui Q; Aksu C; Ay B; Remillard CE; Plagge A; Gardezi M; Dunlap M; Gerstenfeld LC; He Q; Bastepe M
    Front Genet; 2021; 12():680537. PubMed ID: 34220953
    [No Abstract]   [Full Text] [Related]  

  • 32. Functional polymorphisms in the paternally expressed XLalphas and its cofactor ALEX decrease their mutual interaction and enhance receptor-mediated cAMP formation.
    Freson K; Jaeken J; Van Helvoirt M; de Zegher F; Wittevrongel C; Thys C; Hoylaerts MF; Vermylen J; Van Geet C
    Hum Mol Genet; 2003 May; 12(10):1121-30. PubMed ID: 12719376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New mutations at the imprinted Gnas cluster show gene dosage effects of Gsα in postnatal growth and implicate XLαs in bone and fat metabolism but not in suckling.
    Eaton SA; Williamson CM; Ball ST; Beechey CV; Moir L; Edwards J; Teboul L; Maconochie M; Peters J
    Mol Cell Biol; 2012 Mar; 32(5):1017-29. PubMed ID: 22215617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinct patterns of abnormal GNAS imprinting in familial and sporadic pseudohypoparathyroidism type IB.
    Liu J; Nealon JG; Weinstein LS
    Hum Mol Genet; 2005 Jan; 14(1):95-102. PubMed ID: 15537666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GNAS locus and pseudohypoparathyroidism.
    Bastepe M; Jüppner H
    Horm Res; 2005; 63(2):65-74. PubMed ID: 15711092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GNAS-associated disorders of cutaneous ossification: two different clinical presentations.
    Schimmel RJ; Pasmans SG; Xu M; Stadhouders-Keet SA; Shore EM; Kaplan FS; Wulffraat NM
    Bone; 2010 Mar; 46(3):868-72. PubMed ID: 19900597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GNAS1 mutations and progressive osseous heteroplasia.
    Farfel Z
    N Engl J Med; 2002 May; 346(21):1669-71. PubMed ID: 12030264
    [No Abstract]   [Full Text] [Related]  

  • 38. Skeletal abnormalities and extra-skeletal ossification in mice with restricted Gsalpha deletion caused by a renin promoter-Cre transgene.
    Castrop H; Oppermann M; Mizel D; Huang Y; Faulhaber-Walter R; Weiss Y; Weinstein LS; Chen M; Germain S; Lu H; Ragland D; Schimel DM; Schnermann J
    Cell Tissue Res; 2007 Dec; 330(3):487-501. PubMed ID: 17922144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relative functions of Gαs and its extra-large variant XLαs in the endocrine system.
    Bastepe M
    Horm Metab Res; 2012 Sep; 44(10):732-40. PubMed ID: 22730013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progressive osseous heteroplasia caused by a mosaic GNAS mutation.
    Pereda A; Martos-Tello JM; Garin I; Errea-Dorronsoro J; Perez de Nanclares G
    Clin Endocrinol (Oxf); 2018 Jun; 88(6):993-995. PubMed ID: 29464731
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.